| Literature DB >> 22860100 |
Annemarie A Uijen1, Claire W Heinst, Francois G Schellevis, Wil J H M van den Bosch, Floris A van de Laar, Caroline B Terwee, Henk J Schers.
Abstract
BACKGROUND: Continuity of care is widely acknowledged as a core value in family medicine. In this systematic review, we aimed to identify the instruments measuring continuity of care and to assess the quality of their measurement properties.Entities:
Mesh:
Year: 2012 PMID: 22860100 PMCID: PMC3409169 DOI: 10.1371/journal.pone.0042256
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Quality criteria for measurement properties [23].
| Property | Definition | Rating | Quality Criteria |
|
| The degree to which scores for patients who have not changed are the same for repeated measurement under several conditions | ||
| Internal consistency | The degree to which items in a (sub)scale are intercorrelated, thus measuring the same construct | + | + (Sub)scale unidimensional AND Cronbach’s alpha(s) ≥0.70 |
| ? | ? Dimensionality not known OR Cronbach’s alpha not determined | ||
| − | − (Sub)scale not unidimensional OR Cronbach’s alpha(s) <0.70 | ||
| Reliability | The proportion of the total variance in the measurements which is because of ‘true’ | + | + ICC/weighted Kappa ≥0.70 OR Pearson’s r≥0.80 |
| ? | ? Neither ICC/weighted Kappa, nor Pearson’s r determined | ||
| − | − ICC/weighted Kappa <0.70 OR Pearson’s r<0.80 | ||
| Measurement error | The systematic and random error of a patient’s score that is not attributed to true changes in the construct to be measured | + | + MIC > SDC OR MIC outside the LOA |
| ? | ? MIC not defined | ||
| − | − MIC ≤ SDC OR MIC equals or inside LOA | ||
|
| The degree to which the instrument measures the construct(s) it purports to measure | ||
| Content validity | The degree to which the content of an instrument is an adequate reflection of the construct to be measured | + | + The target population considers all items in the questionnaire to be relevant AND considers the questionnaire to be complete |
| ? | ? No target population involvement | ||
| − | − The target population considers items in the questionnaire to be irrelevant OR considers the questionnaire to be incomplete | ||
| Structural validity | The degree to which the scores of an instrument are an adequate reflection of the dimensionality of the construct to be measured | + | + Factors should explain at least 50% of the variance |
| ? | ? Explained variance not mentioned | ||
| − | − Factors explain <50% of the variance | ||
| Hypothesis testing(construct validity) | The degree to which the scores of an instrument are consistent with hypotheses (e.g. with regard to internal relationships, relationships to scores of other instruments, or differences between relevant groups) based on the assumption that the other instru | + | + Correlation with an instrument measuring the same construct ≥0.50 OR at least 75% of the results are in accordance with the hypotheses AND correlation with related constructs is higher than with unrelated constructs |
| ? | ? Solely correlations determined with unrelated constructs | ||
| − | − Correlation with an instrument measuring the same construct <0.50 OR <75% of the results are in accordance with the hypotheses OR correlation with related constructs is lower than with unrelated constructs | ||
|
| |||
| Responsiveness | The ability of an instrument to detect change over time in the construct to be measured | + | + (Correlation with an instrument measuring the same construct ≥0.50 OR at least 75% of the results are in accordance with the hypotheses OR AUC ≥0.70) AND correlation with related constructs is higher than with unrelated constructs |
| ? | ? Solely correlations determined with unrelated constructs | ||
| − | − Correlation with an instrument measuring the same construct <0.50 OR <75% of the results are in accordance with the hypotheses OR AUC <0.70 OR correlation with related constructs is lower than with unrelated constructs |
The word ‘true’ must be seen in the context of the classical test theory, which states that any observation is composed of two components - a true score and error associated with the observation. ‘True’ is the average score that would be obtained if the scale were given an infinite number of times. It refers only to the consistency of the score and not to its accuracy.
MIC = minimal important change, SDC = smallest detectable change, LOA = limits of agreement, ICC = intraclass correlation coefficient, AUC = area under the curve.
+ = positive rating, ? = indeterminate rating, − = negative rating.
Levels of evidence for the overall quality of the measurement property [22].
| Rating | Criteria |
| + + + or − − − | Consistent findings in multiple studies of good methodological quality OR in one study of excellent methodological quality |
| + + or − − | Consistent findings in multiple studies of fair methodological quality OR in one study of good methodological quality |
| + or − | One study of fair methodological quality |
| +/− | Conflicting findings |
| ? | Only studies of poor methodological quality |
+ = positive rating, ? = indeterminate rating, − = negative rating.
Figure 1Search strategy resulting in 4749 articles from PubMed, 2366 articles from Embase and 349 articles from PsycInfo.
Description of identified instruments.
| Instrument | Reference number | Year of publication | Measurement aim | Target population | Language | No of items and subdomains | Response options | Domains of continuity of care |
| CPCI | 31 | 1997 | To measure several components of the delivery of primary care from the perspective of the patient | Patients visiting family practice physicians | English | 19 items in 4 subdomains | 5-point scale (range 1–5, mean factor scale score 1–5) | Personal continuity Team continuity Cross-boundary continuity |
| VCC | 27 | 1998 | To measure continuity of care from the patient perspective | Patients living at home | Dutch | 126 items in 4 subdomains | 5-point scale (range 1–5, total range 1–5) | Team continuity Cross-boundary continuity |
| CCI | 26 | 2000 | To measure continuity of care from the perspective of elders hospitalised for a chronic illness and their family caregivers | Elders hospitalised for a chronic illness | English | 12 items in 4 subdomains | 7-point scale (range 1–7, total range 12–84) | Personal continuity Team continuity Cross-boundary continuity |
| CONNECT | 43 | 2003 | To measure continuity of care for mental health services | Patients who have serious mental illness | English | 59 items in 14 subdomains | 5-point scale (range 1–5). Each subdomain was scored by summing the items and then rescaling to give a score out of 100 | Team continuity Cross-boundary continuity |
| CPCQ | 40 | 2003 | To measure coordination of health care | Predominantly elderly patients with complex and chronic care needs | English | 31 items in 7 subdomains | Most items were rated on a 5-point scale (range 1–5), 4 items were rated on a 3-point scale (range 1–3) | Team continuity Cross-boundary continuity |
| ACSS-MH | 24; 30; 37 | 2004 | To measure continuity of care for mental health services from the patient/client perspective | Patients using mental health services | English | 32 items in 3 subdomains | 5-point scale (range 1–5, mean factor scale score 1–5) | Personal continuity Team continuity Cross-boundary continuity |
| CCPS-I | 42 | 2004 | To measure the extent of continuity of care that staff (primary counselors/case managers) of substance use disorder programs provide to individual patients | Substance use disorder program staff (primary counselors/case managers) | English | 23 items in 4 subdomains | Three subscales were scored on a 4-point scale, one subscale is scored as the mean of two percentages | Personal continuity Cross-boundary continuity |
| CCPS-P | 42 | 2004 | To measure continuity of care from the perspective of substance use disorder program directors | Substance use disorder program directors | English | 23 items in 4 subdomains | Three subscales were scored on a 4-point scale, one subscale is scored as the mean of two percentages | Personal continuity Cross-boundary continuity |
| DCCS | 29 | 2004 | To measure continuity of care from the perspective of patients with diabetes | Diabetic patients | English | 47 items in 5 subdomains | 5-point scale (range 1–5, total score range 47–235) | Team continuity Cross-boundary continuity |
| HCCQ | 34; 39 | 2004 | To assess continuity of care from the perspective of patients with congestive heart failure and atrial fibrillation | Patients hospitalised for either congestive heart failure or atrial fibrillation | English | 33 items in 3 subdomains | 5-point scale (range 1–5, total range 1–5) | Personal continuity Team continuity Cross-boundary continuity |
| ECC-DM | 33 | 2006 | To measure continuity of care in type 2 diabetes mellitus | Type 2 diabetic patients | English | 19 items in 4 subdomains | 6-point scale. Each subdomain was scored by summing the items and then rescaling to give a score out of 25 (total score range 0–100). | Personal continuity Team continuity Cross-boundary continuity |
| King et al. (nameless instrument) | 38 | 2008 | To measure continuity of care in patients with cancer | Patients with cancer | English | 18 items in 1 subdomain | 5-point scale (range 0–4, total range 0–72) | Team continuity |
| CONTINU-UM | 41 | 2008 | To measure continuity of care in patients with severe mental illness | Patients who have severe mental illness | English | 32 items in 16 subdomains | 5-point scale (range unclear) | Personal continuity Team continuity Cross-boundary continuity |
| DCCQ | 44 | 2008 | To measure continuity of care in type 2 diabetes mellitus | Type 2 diabetic patients | Chinese | 46 items in 8 subdomains | 6-point scale, except for one subdomain (5-point scale). Each subdomain was scored by summing the items and then rescaling to give a score out of 100. | Personal continuity Team continuity Cross-boundary continuity |
| PCCQ | 35 | 2008 | To measure patient perceptions of factors impacting continuity of care following dischargefrom hospital | Patients previously hospitalised | English | 27 items in 6 subdomains | 5-point scale (range 1–5) | Personal continuity Team continuity Cross-boundary continuity |
| Ahgren et al. (nameless instrument) | 25 | 2009 | To assess the integration of welfare services from the perspective of the service users | Users of welfare services | Swedish | 22 structured and open questions in 3 subdomains | The structured questions were rated on different ordinal scales (total range unclear) | Team continuity Cross-boundary continuity |
| CRP-PIM | 36 | 2009 | To assess the communication among physician consultants and referring physicians | Referring physicians | English | 13 items in 2 subdomains | 6-point scale (range 1–6) | Team continuity Cross-boundary continuity |
| CSI Survey | 28 | 2009 | To measure integration of cancer services | Healthcare providers and administrators that had regular opportunities to interact with the cancer system | English | 54 items in 4 subdomains | 5-point scale (range unclear) | Team continuity Cross-boundary continuity |
| Gulliford et al. (nameless instrument) | 32 | 2011 | To measure continuity of care from the perspective of patients with a long-term illness | Patients with a long-term ilness | English | 16 items in 2 subdomains | 4-point scale. In order to simpify further analysis, the authors used dichotomized item responses (0 or 1) | Personal continuity Team continuity Cross-boundary continuity |
| CCCQ | 45 | 2011 | To measure patients’ experience of cancer care coordination | Cancer patients in the treatment phase of the cancer journey | English | 20 items in 2 subdomains | 5-point scale (range 1–5, total range 20–100) | Team continuity Cross-boundary continuity |
| NCQ | 15; 16 | 2011 | To measure continuity of care from the patients’ perspective across primary and secondary care settings | All types of patients, regardless of care setting and morbidity | Dutch | 28 items in 3 subdomains | 5-point scale (range 1–5) | Personal continuity Team continuity Cross-boundary continuity |
Description of identified study populations.
| Article | Reference number | Instrument | Study population | Setting | N | Mean age (SD) | Male (%) | Country |
| Flocke | 31 | CPCI | Patients visiting family practice physicians | 138 family practices | 2899 | 42 (23) | 38 | USA |
| Casparie et al. | 27 | VCC | Patients living at home suffering from multiple sclerosis, rheumatoid artritis, astma, COPD, dementia or a mental impairment | Primary care | ±1000 | ? | The Netherlands | |
| Bull et al. (Phase I+ II) | 26 | CCI | Elders ( | Hospital | 32 | 69.3 (8.9) | ? | USA |
| Bull et al. (Phase III) | 26 | CCI | Elders ( | Hospital | 121 | Range: 55–89 years | ? | USA |
| Bull et al. (Phase IV) | 26 | CCI | Elders ( | Hospital | 135 | 74.1 (9.0) | ? | USA |
| Ware et al. | 43 | CONNECT | Patients diagnosed with serious mental illness | Public mental health services | 400 | Range: 18–71 years | 63 | USA |
| McGuiness et al. | 40 | CPCQ | 1. Patients with chronic complex health problems who could benefit from improved coordination of their health and social care 2. Patients with chronic pain | 1. General practice 2. General practice and a community-based chronic pain management course | 1380 | 59.1 | 39 | Australia |
| Adair et al. | 24 | ACSS-MH | Patients in mental health services | Mental health services | 317 | Canada | ||
| Durbin et al. | 30 | ACSS-MH | Users of community and outpatient mental health programs | Mental health programs | 215 | 25 years and younger: 6.6% 65+: 4.2% | 37.9 | Canada |
| Joyce et al. | 37 | ACSS-MH | Patients with a severe mental illness (psychotic disorder, bipolar disorder, or unipolar depressive disorder of at least 24 months duration) | Mental health services | 441 | 42.5 (10.3) | 41.0 | Canada |
| Schaefer et al. | 42 | CCPS-I | Staff (primary counselors/case managers) of substance use disorder programs | Specialized mental health care | ? | ? | ? | USA |
| Schaefer et al. | 42 | CCPS-P | Directors of different substance use disorder treatment programs | Specialized mental health care | 117 | ? | ? | USA |
| Dolovich et al. | 29 | DCCS | Patients with diabetes | A group health centre consisting of 33 family physicians and 31 specialists | 60 | 60.8 (11.4) | 56.7 | Canada |
| Kowalyk et al. | 39 | HCCQ | Patients who had been hospitalized approximately six months earlier for either congestive heart failure or atrial fibrillation | Hospitals | 83 | 74 (12) | 56.6 | Canada |
| Hadjistravropoulos et al. | 34 | HCCQ | Patients who had been hospitalized at least six months earlier for either congestive heart failure or atrial fibrillation | Hospitals | 350 | 73.9 (range: 40–99 years) | 54.0 | Canada |
| Gulliford, Naithani et al. | 33 | ECC-DM | Patients with type 2 diabetes | 19 family practices | 193 | 65 (range: 32–90 years) | 49.7 | UK |
| King et al. | 38 | Nameless | Patients with breast, lung or colorectal cancer | National Cancer Networks | 199 | 61.2 (11.8) | 31.7 | UK |
| Rose et al. | 41 | CONTINU-UM | Patients who had a diagnosis of psychosis and had been in touch with services for at least 2 years | Community mental health teams | 167 | 43 | 56 | UK |
| Wei et al. | 44 | DCCQ | Patients with type 2 diabetes | Community health centre | 338 | 68.7 (9.7) | 32.2 | China |
| Hadjistravropoulos et al. | 35 | PCCQ | Patients discharged from either an orthopaedics unit or a family medicine unit | Hospitals | 204 | 64.9 (17.4) | 40.2 | Canada |
| Ahgren et al. | 25 | Nameless | Users of different institutions in the rehabilitation field that provide services to people who have been ill or unemployed for a long time | Institutions in the rehabilitation field | 454 | 40 | 40 | Sweden |
| Hess et al. | 36 | CRP-PIM | Physicians referring to consultants (internists and subspecialists) | Hospital | 12212 | 47 (3.9) | 76 | USA |
| Dobrow et al. | 28 | CSI | Healthcare providers and administrators that had regular opportunities to interact with the cancer system | Hospitals and community care access centres | 1769 | Between 40–60: 71% | 31.0 | Canada |
| Gulliford, Cowie et al. | 32 | Nameless | Patients aged 60 years or older | General practice | 1125 | ? | 45.5 | UK |
| Young et al. | 45 | CCCQ | 1. Patients in follow-up for any cancer that had been treated 3–12 months previously 2. Patients with a newly diagnosed colorectal cancer | Hospital | 686 | 66.1 (13.3) | 53.2 | Australia |
| Uijen, Schellevis et al. | 15 | NCQ | Patients with one or more chronic diseases | General practice | 288 | 64.6 | 46.2 | The Netherlands |
| Uijen, Schers et al. | 16 | NCQ | Patients with one or more chronic diseases | General practice and hospital/outpatient department | 268 | 62.2 | 48.5 | The Netherlands |
Methodological quality of each article per measurement property and instrument (COSMIN Checklist).
| Article | Reference number | Internal Consistency | Reliability | Measurement Error | Content Validity | Structural Validity | Hypotheses Testing |
| CPCI | |||||||
| Flocke | 31 | Good | − | − | Excellent | Good | Fair |
| VCC | |||||||
| Casparie et al. | 27 | Good | − | − | Excellent | Good | − |
| CCI | |||||||
| Bull et al. (Phase I+II) | 26 | Poor | − | − | Fair | − | Fair |
| Bull et al. (Phase III) | 26 | Excellent | − | − | − | Excellent | Good |
| Bull et al. (Phase IV) | 26 | Excellent | Excellent | − | − | Excellent | Fair |
| CONNECT | |||||||
| Ware et al. | 43 | Poor | Good | − | Good | − | Poor |
| CPCQ | |||||||
| McGuiness et al. | 40 | Excellent | − | − | Fair | Fair | Fair |
| ACSS-MH | |||||||
| Adair et al. | 24 | Fair | Fair | − | Excellent | Fair | − |
| Durbin et al. | 30 | Excellent | − | − | − | Excellent | Fair |
| Joyce et al. | 37 | Good | − | − | − | Good | Fair |
| CCPS-I | |||||||
| Schaefer et al. | 42 | Poor | − | − | Poor | − | − |
| CCPS-P | |||||||
| Schaefer et al. | 42 | Poor | − | − | Fair | − | Poor |
| DCCS | |||||||
| Dolovich et al. | 29 | Poor | Fair | − | Fair | Poor | Fair |
| HCCQ | |||||||
| Kowalyk et al. | 39 | Poor | − | − | Fair | − | Good |
| Hadjistravropoulos et al. | 34 | Excellent | − | − | − | Good | Good |
| ECC-DM | |||||||
| Gulliford, Naithani et al. | 33 | Excellent | − | Poor | − | Good | Poor |
| King et al. (Nameless) | |||||||
| King et al. | 38 | Poor | Fair | − | Excellent | − | − |
| CONTINU-UM | |||||||
| Rose et al. | 41 | − | Fair | Fair | Poor | − | − |
| DCCQ | |||||||
| Wei et al. | 44 | Fair | − | − | Fair | Poor | Fair |
| PCCQ | |||||||
| Hadjistravropoulos et al. | 35 | Poor | − | − | Poor | Poor | Good |
| Ahgren et al. (Nameless) | |||||||
| Ahgren et al. | 25 | Poor | − | − | Fair | − | − |
| CRP-PIM | |||||||
| Hess et al. | 36 | − | Poor | − | − | Fair | − |
| CSI | |||||||
| Dobrow | 28 | Poor | − | − | Excellent | Poor | − |
| Gulliford et al. (nameless) | |||||||
| Gulliford, Cowie et al. | 32 | Fair | − | − | Poor | Fair | − |
| CCCQ | |||||||
| Young et al. | 45 | Excellent | Excellent | − | Excellent | Excellent | Poor |
| NCQ | |||||||
| Uijen, Schellevis et al. | 15 | Excellent | − | − | Fair | Poor | − |
| Uijen, Schers et al. | 16 | Excellent | Excellent | Excellent | − | Poor | Excellent |
Cross-cultural validity, criterion validity and responsiveness were not evaluated
−: no information available.
Quality of measurement properties and the interpretability per instrument.
| Measurement properties | Interpretability | |||||||||
| Instrument | Internal Consistency | Reliability | Measurement Error | Content Validity | Structural Validity | Hypotheses Testing | Differences in scores between subgroups | Floor/ceiling effects of subdomain(s) | Minimal important change (MIC) | |
| CPCI | − − | na | na | + + + | + + | + | Not reported | Unknown | Unknown | 4, 3 positief |
| VCC | − − | na | na | + + + | + + | na | Not reported | Unknown | Unknown | 3, 2 positief |
| CCI | + + + | − − − | na | + | + + + | +/− | Not reported | Floor and ceiling effect | Unknown | 5, 3 positief |
| CONNECT | ? | − − | na | + + | na | ? | Not reported | Floor effect | Unknown | 4, 1 positief |
| CPCQ | − − − | na | na | + | + | + | Not reported | Unknown | Unknown | 4, 3 positief |
| ACSS-MH | +/− | − | na | + + + | − − − | + | Reported | Unknown | Unknown | 5, 2 positief |
| CCPS-I | ? | na | na | ? | na | na | Not reported | Unknown | Unknown | 2, 0 positief |
| CCPS-P | ? | na | na | + | na | ? | Not reported | Unknown | Unknown | 3, 1 positief |
| DCCS | ? | + | na | + | ? | − | Reported | Ceiling effect | Unknown | 5, 2 positief |
| HCCQ | + + + | na | na | + | − − | + + + | Not reported | Unknown | Unknown | 4, 3 positief |
| ECC-DM | − − − | na | ? | na | + + | ? | Reported | Unknown | Unknown | 4, 1 positief |
| King et al. (Nameless) | ? | + | na | + + + | na | na | Not reported | Unknown | Unknown | 3, 2 positief |
| CONTINU-UM | na | + | ? | ? | na | na | Not reported | Unknown | Unknown | 3, 1 positief |
| DCCQ | + | na | na | + | ? | − | Not reported | No floor/ceiling effect | Unknown | 4, 2 positief |
| PCCQ | ? | na | na | ? | ? | + + | Reported | Unknown | Unknown | 4, 1 positief |
| Ahgren et al. (Nameless) | ? | na | na | + | na | na | Not reported | Unknown | Unknown | 2, 1 positief |
| CRP-PIM | na | ? | na | na | − | na | Not reported | Ceiling effect | Unknown | 2, 0 positief |
| CSI | ? | na | na | + + + | ? | na | Not reported | No floor/ceiling effect | Unknown | 3, 1 positief |
| Gulliford et al. (nameless) | + | na | na | ? | + | na | Reported | Unknown | Unknown | 3, 2 positief |
| CCCQ | + + + | − − − | na | + + + | + + + | ? | Not reported | Ceiling effect | Unknown | 5, 3 positief |
| NCQ | + + + | + + + | ? | + | ? | + + + | Reported | No floor/ceiling effect | Unknown | 6, 4 positief |
+++ or −−− = strong evidence positive/negative result, ++ or − = moderate evidence positive/negative result, + or − = limited evidence positive/negative result, +/− = conflicting evidence, ? = unknown, due to poor methodological quality.
na = no information available.
Cross-cultural validity, criterion validity and responsiveness were not evaluated.